Conclusions-This series confirmed the prognostic power of former classifications and showed the prognostic power of other variables (mucin, non-invasive adenomatous component, CA19.9). (Gut 1997; 40: 350-355) 
Primary malignant tumours rarely occur in the ampulla of Vater. Pancreatoduodenectomy with or without resection of the pylorus is the procedure of choice. Prognosis is radically different from tumours of the head of the pancreas as five year survival after complete surgical resection is 30% to 60%. Several adjuvant postoperative treatments have been proposed in an attempt to improve survival rates. Splinter et all did not find any improvement in three year survival after chemotherapy. Willet et al2 3 proposed postoperative irradiation with or without 5-fluorouracil for their patients and noted a reduction in the rate of local recurrence but no beneficial effect on survival. A recent randomised controlled study in Scandinavia4 showed a significant improvement in mean overall survival and in two year survival after postoperative chemotherapy in patients undergoing curative surgery for cancer of the head of the pancreas or the papilla (14/61 cases). The implications of these results are, however, subject to discussion as the series were either non-randomised, or included only a few patients, or reported cancer of the pancreas and the papilla together. In addition, as for adenocarcinoma of the colon, the rationale for treating all patients undergoing what is considered to be a curative surgical procedure is not always clear. A more appropriate approach would be to reserve adjuvant therapy for patients at higher risk of recurrence. There are indeed several classifications aimed at predicting prognosis. More recently, certain criteria based on histochemistry (mucin typing) or immunohistochemistry (CEA, C19.9, Ki67, or p53) have been useful for other types of tumours. In this retrospective study we Patients who were treated with a palliative procedure (as defined operatively) or had invaded margins (in the pathology report) and those who had an in situ lesion or dysplasia were excluded from the study.
Age, sex, signs leading to diagnosis (jaundice, pain, anaemia, bleeding), and preoperative endoscopical findings were obtained from the hospital records of the 45 patients. After surgery, the macroscopic aspect of the tumour (vegetating, nodular, ulceration), the largest diameter, and initial localisation (true tumour of the ampulla, or tumour arising from periampullary duodenal surface mucosa, from the common bile duct, or pancreatic duct) were recorded. All pathology slides were then reviewed prospectively focusing on infiltration of the tumour, degree of malignancy, and differentiation according to the criteria of Von Dinges.
These data were used to assign patients in the following classifications: (1) initial and modified Blumgart and Kennedy classifications5; (2) Streptavidin-biotin coupled with peroxidase was used to label these four antibodies. Final detection was based on antigen-antibody reactions with colorimetric detecting using H202 and chromogenic 3,3 diaminobenzidine tetrahydrochloride (DAB). Anti-CEA and anti-CAl9.9 immunolabelling were expressed semiquantitatively as: no labelling=O, labelling on at least one third of the tumour surface area=+, labelling of at least two thirds of the tumour surface area=++, and labelling of the entire tumour surface area=+++. Labelling distribution was also noted as apical or diffuse. Results for anti-p53 and anti-Ki67 were determined as the mean of 10 fields with a X 400 magnification. Results were expressed as percentage of labelled cells.
Statistical analysis Mean (SD) was used to analyse quantitative variables. Kaplan-Meier curves were drawn to evaluate specific survivals and were compared using the log rank test or the generalised Wilcoxon test. For the two continuous variables, anti-p53 and anti-Ki67 labelling, the cut off point was set at 5% for p53 and at 15% for Ki67. The x2 test and the exact Fisher test were used to analyse the association of several variables for prognostic value. Significance was set at 5%.
Results

Descriptive analysis
There were 45 patients -25 men and 20 women, mean age 62-8 (SD 101) (range 13-80) years. The youngest patient was a women with familial adenomatous polyposis (the only patient with a similar clinical situation in this study). The most frequent clinical signs were jaundice (n=32, 71%), abdominal pain (n=26, 58%), anaemia (n=9, 20%), and haemorrhage (n=5, 11%). The delay between onset of symptoms and diagnosis was short (3 (SD 2 8) months). Weight loss was noted in 51% of the cases. Preoperative endoscopical biopsies were obtained for 29 patients and were positive in 23 (80%). Pancreatoduodenectomy was performed in 37 cases (82%), pancreatoduodenectomy with resection of the entire pancreas in five cases (11%), and ampullectomy alone in three cases (7%). Three patients (6.7%) died during the immediate postoperative period and overall postoperative morbidity was 22% (three haemorrhages, three major infections, two abscesses, and one case each of respiratory complications and ulceration of the anastomosis).
Macroscopically the tumours measured 2-5 (SD 1 9) cm in diameter. There were 21 vegetating tumours (47%), 14 nodular tumours (31%), and 10 ulcerated tumours (22%). Strictly ampullary localisation was seen in 28 cases (62%). Other localisations were: lower end (within the Oddi sphincter and ampulla) of the common bile duct (n=5, 1 1O%); end (within the Oddi sphincter and ampulla) of the pancreatic duct alone (n= 1); periampullary 14 and cytoplasmic labelling in 25. Labelling for CAl 9.9 was negative or weak in 13 cases and strongly positive in 32 with an apical distribution in nine and cytoplasmic labelling in 34.
Immunolabelling for p53 was detected in 22 cases (49%) and for Ki67 in 23 (5 1%). Table I shows the results of the different classifications of patients. The probability of survival at two years was 60 (SD 7)%/o, at five years it was 44 (9)%, and at 10 years 38 (SD 12)% (five patients at risk) ( Figure) . In all, 25 of the patients have died including the early postoperative deaths. The causes of death were: early postoperative death in three cases; in two cases death occurred early, less than one year after surgery, of unknown causes; one patient died after a myocardial infarction and in the others deaths were related to extension of the ampullary carcinoma.
Prognostic factors Among the 22 factors studied, 11 were identified as having prognostic value. Table II gives their degree of significance and the five year survival rate in each sub-group. A positive correlation between prognostic factors was found in five of the possible combinations: The descriptive data obtained in this series are similar to those reported in the medical literature115: mean age slightly over 60 years, slight male predominance, and frequent jaundice, pain, and haemorrhage. Survival at five years in our patients was 44 (SD 7)%, which is high compared with that reported in the literature despite the exclusion of in situ tumours from the analysis. Preoperative endoscopical exploration, performed in 29 of our patients, gave the diagnosis of malignancy in 80%. This is close to the diagnostic yield of endoscopical biopsies reported in one Japanese series,'6 in which positive pathology results were obtained in 70%. To improve endoscopical diagnosis, other endoscopical techniques, including biopsy after endoscopic sphincterotomy or snare biopsies,17 may be indicated.
Pancreatoduodenectomy is the treatment of choice for tumours of the ampulla of Vater. Local procedures such as simple ampullectomy have been proposed to reduce operative mortality. In a recent review, Allema et al '2 reported lower mortality (6%) and a better five year survival rate (47%) for ampullectomy than for pancreatoduodenectomy (120/o-35%).
Early in our series we performed local resection in three cases. One patient had to be reoperated on for haemorrhage and the tumour recurred in all three patients. Pancreatoduodenectomy is well tolerated as confirmed by the outcome in this series (mortality=6-7%/o, morbidity=22%).
Multivariate analysis could not be performed due to the few patients and deaths (n=24) in this series. However, data for 22 variables were analysed and 11 were found to have prognostic value. Among these there were five combinations showing correlations between two variables (exact Fisher test or x2 test).
Neither age of the patients (> or <60 years) nor sex had an effect on prognosis. However, all of the early deaths (immediate postoperative period or within six months of surgery) occurred in patients over 60. The only clinical variable tested, jaundice, was found to have an unfavourable effect on prognosis. This finding, also reported by several other authors, i5 18 is related to the fact that jaundice is an expression of spread of disease14 just as is the association we found between the presence of jaundice and a more severe stage in the Martin classification.
Among the other macroscopic variables studied, neither tumour size nor the macroscopic aspect (vegetative, nodular, or ulceration) had prognostic value. Previous reports are contradictory. 12 15 19-22 The macroscopic histological classifications initially described by Blumgart and Kennedy5 and then modified by Martin, 6 did not isolate any differences in prognosis. This may be related to the rather subjective nature of these classifications. The other macroscopic criterion examined, tumour localisation, was found to affect prognosis as tumours strictly limited to the ampulla had a better prognosis. This has previously been reported."1 23 Tumours which originate at the sphincteral end of the pancreatic duct seem to have poor prognosis." It may, however, be difficult to distinguish the point of origin of extended tumours, and an analysis of mucin secretion can provide interesting results" because different sets of tissues secrete different mucins. Neoplasia is, however, usually associated with a modification in mucin secretion which in itself may have prognostic power.
Most of the variables which had prognostic value were those distinguished by histology or histochemical or immunohistochemical methods. In this series, a non-invasive adenomatous component was associated with better prognosis. Adenomatous residues are often found within tumours of the ampulla24 25 confirming the fact that adenomas of the papilla are precancerous lesions, a finding which would be colloborated by the demonstration of increasing immunoreactivity to CEA and CAl9.9 with increasing degrees of dysplasia.'4 Adopting the criteria of Yamauchi et al to define the presence of adenomatous residues may be too restrictive, but the use of a cut off value (20%) permits the differentiation of cases in which residues are important from those in which the area involved is minor or absent. There are two possible explanations as to why some cancers of the ampulla have no detectable adenomatous component. Either tumoural extension has already destroyed the adenomatous tissue or certain cancers develop without going through an adenoma stage. Such adenomatous residues are described in about one third of the cases of cancer of the colon26 and have a frequency inversely proportional to tumour size. Such an association has been suggested for tumours of the papilla25 but in two recently reported series,9 27 as in ours, the authors were unable to show any relation. In addition, we found, as did Yamauchi et al in two series of 26 and 23 cases,9 28 that there was a considerable difference in prognosis for tumours with a non-invasive adenomatous component. Such tumours showed a better prognosis (five year survival 78 and 75% v 22 and 11% in the series of Yamaguchi et al and 68% v 27% in our series). It could thus be hypothesised that tumours without a noninvasive adenomatous component correspond to aggressive tumours with a rapid progression destroying the adenomatous tissue or to new tumours of the ampulla which have not gone through an adenoma stage; both cases would have a particularly severe prognosis. We also showed an association between the presence of a non-invasive adenomatous component and the Talbot classification, which takes into consideration both tumour infiltration and differentiation. This suggests that these tumours would also be less well differentiated. The We also analysed CEA, CA19.9, Ki67, and p53 expression using immunohistochemistry.
The only effect on prognosis found was for CA19.9, which seemed to have an unfavourable influence both for labelling intensity and localisation, which were associated. For certain authors, apical labelling is not an entity in itself, but rather corresponds to weaker labelling than diffuse cytoplasmic labelling. 22 The poor prognosis of CA19.9 positive cancers of the ampulla of Vater has been noted previously.'4 21 22 Whether this unfavourable affect is an independent factor or simply related to the effect of other factors remains to be determined. Nakao et In conclusion, the findings in this series of 45 tumours of the ampulla of Vater treated by curative resection showed that 11 factors were significantly correlated with survival rate. Among these factors, jaundice and tumour localisation are well known for their prognostic power. For several others such as the histoprognostic classifications (Martin, 6 Yamaguchi and Enjoji, 7 Talbot et al, 8 pTNM) there is a logical explanation for the relation with outcome. Other factors such as the type of mucin secreted, the presence of a non-invasive adenomatous component, and CA19.9 immunoreactivity are less well known. Some of these variables (mucin secretion, CA19.9 immunoreactivity on endoscopical biopsies) 2' or even depth of extension (using echoendoscopy or echolaparoscopy),34 3 can be determined preoperatively and would therefore lead to the use of a neoadjuvant treatment. All these factors can also be evaluated postoperatively to determine whether adjuvant treatment is indicated. The aim of such adjuvant therapy would be to increase five year survival further by treating patients with factors of poor prognosis. For example, based on factors showing the highest level of significance in our series, the prognosis can be determined with further precision if two factors are associated. Thus for patients in stage 1 in the classification of Talbot et al,' an assessment of sulphomucin secretion can identify non-secretors, who have a good prognosis (100% survival at five years) and secretors with poor prognosis (41% survival at five years). Likewise, CA 19.9 immunoreactivity can distinguish between patients with good prognosis (CA19.9 negativity, five year survival 100%) and those with poor prognosis (CA19.9 positivity, five year survival 36%). However, this retrospective series with few patients can only provide tentative conclusions which must be validated in a prospective study. If validated, these findings could lead to clinical trials of adjuvant therapy proposed on the basis of histoprognosis.
